AL
Alibaba Health Information Technology Limited
ALBBY · OTC
$7.50 +3.73% (+$0.27)
1M -10.07%
Market Cap ¥39.0B
P/E Ratio 27.25x
Div. Yield 7.95%
ROE 8.43%
Bulios Fair Price
$3.93
47.6% downside
Current Price
$7.5
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ALBBY is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
50 /100
Fair EV/EBITDA 22.75x
P/S 1.28x
P/B 2.39x
Growth
85 /100
Growing FCF growth 49.79%
Book val. growth 4.98%
Rev. growth 14.14%
Profitability
32 /100
Weak Net margin 4.68%
Op. margin 5.15%
FCF margin 4.50%
Quality
55 /100
Average ROE 8.43%
ROA 6.76%
Asset turnover 1.44x
Debt
100 /100
Low Current ratio 2.59x
Int. coverage 598.92x
Net debt/EBITDA -1.35x
Stability
36 /100
Moderate Rev. volatility 14.60%
EPS volatility 145.85%
Profitable years 3
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ALBBY
Online
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Di Fan Shen
Employees
1,394
Headquarters
Hong Kong